Next Article in Journal / Special Issue
Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics
Previous Article in Journal / Special Issue
Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region

by
Alba Maria Ropero
,
Hannah Kurtis
,
Lauren Vulanovic
,
Pamela Bravo-Alcántara
,
Maite Vera Antelo
and
Margherita Ghiselli
*
Pan American Health Organization, Washington, DC 20037, USA
*
Author to whom correspondence should be addressed.
Vaccines 2024, 12(7), 812; https://doi.org/10.3390/vaccines12070812
Submission received: 31 May 2024 / Revised: 8 July 2024 / Accepted: 12 July 2024 / Published: 22 July 2024

Abstract

Vaccination Week in the Americas (VWA) is a yearly regional initiative that promotes the benefits of vaccination to all persons in the region. In its 22-year history, more than 1.15 billion people have been reached under the framework of VWA across more than 40 countries and territories. This review examines multiple PAHO and WHO data points, documents and reports related to measles/rubella vaccination coverage and VWA since its inception. Its goal is to document the impact that the VWA has had in maintaining and accelerating measles and rubella disease elimination, in the context of PAHO’s Disease Elimination Initiative. The results suggest that VWA’s contributions to measles and rubella elimination have been substantial. Every year, VWA promotes (a) renewed political commitment to the immunization program from the highest political authorities of Member States; (b) vaccination operations to close immunity gaps, recover under-vaccinated persons, and reach chronically underserved populations; and (c) the dissemination of messages on the benefits of vaccination through regional and national communications campaigns. VWA will continue to be an important contributor to disease elimination efforts in the Americas, even as new targets are set in response to the evolving epidemiological landscape.
Keywords: measles; rubella; elimination; immunity gap; Vaccination Week in the Americas measles; rubella; elimination; immunity gap; Vaccination Week in the Americas

Share and Cite

MDPI and ACS Style

Ropero, A.M.; Kurtis, H.; Vulanovic, L.; Bravo-Alcántara, P.; Vera Antelo, M.; Ghiselli, M. Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region. Vaccines 2024, 12, 812. https://doi.org/10.3390/vaccines12070812

AMA Style

Ropero AM, Kurtis H, Vulanovic L, Bravo-Alcántara P, Vera Antelo M, Ghiselli M. Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region. Vaccines. 2024; 12(7):812. https://doi.org/10.3390/vaccines12070812

Chicago/Turabian Style

Ropero, Alba Maria, Hannah Kurtis, Lauren Vulanovic, Pamela Bravo-Alcántara, Maite Vera Antelo, and Margherita Ghiselli. 2024. "Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region" Vaccines 12, no. 7: 812. https://doi.org/10.3390/vaccines12070812

APA Style

Ropero, A. M., Kurtis, H., Vulanovic, L., Bravo-Alcántara, P., Vera Antelo, M., & Ghiselli, M. (2024). Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region. Vaccines, 12(7), 812. https://doi.org/10.3390/vaccines12070812

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop